Expression of CK8 and CK17, specific epithelial markers, by oral squamous cell carcinoma cell lines
Journal of Dental School, Shahid Beheshti University of Medical Sciences,
Vol. 35 No. 4 (2017),
5 March 2019
,
Page 122-126
https://doi.org/10.22037/jds.v35i4.24592
Abstract
Objectives Oral squamous cell carcinoma (OSCC) is among the most common cancers worldwide. This study aimed to assess the expression of CK8 and CK17 by OSCC cell lines in Iranian patients.
Methods This observational study was conducted on three OSCC cell lines with a minimum of 45 passages. Cells isolated from three patients with OSCC were cultured and passaged. Expression of CK8 and CK17 epithelial markers was assessed using reverse-transcription polymerase chain reaction. Data were presented qualitatively.
Results The results confirmed the expression of CK8 and CK17 mRNA in three groups. Expression of these markers was different in the three specimens based on their degree of malignancy.
Conclusion Since CK8 and CK17 were expressed in different superficial and basal layers in the three specimens, epithelial origin of these cells was confirmed. This study can pave the way for further cancer research and designing new treatments- carcinoma
- cell line
- mouth
- squamous cell
How to Cite
References
Petersen PE. Oral cancer prevention and control—The approach of the World Health Organization. Oral Oncol. 2009;45:454–460.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011r;61:69–90.
de Camargo Cancela M, de Souza DL, Curado MP. International incidence of oropharyngeal cancer: a population-based study. Oral Oncol. 2012;48:484–490.
Hamid S, Lim KP, Zain RB, Ismail SM, Lau SH, Mustafa WM, et al. Establishment and characterization of Asian oral cancer cell lines as in vitro models to study a disease prevalent in Asia. Int J Mol Med. 2007;19:453–460.
Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114:806–816.
Kendall K, Repp MR, Jilka T, Kingsley K. Biomarker screening of oral cancer cell lines revealed sub-populations of CD133-, CD44-, CD24- and ALDH1- positive cancer stem cells. J Cancer Res Ther. 2013;1:111–118.
Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck. 2007;29:163–188.
Zhang Z, Filho MS, Nor JE. The biology of head and neck cancer stem cells. Oral Oncol. 2012;48:1–9.
Felthaus O, Ettl T, Gosau M, Driemel O, Brockhoff G, Reck A, et al. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. Biochem Biophys Res Commun. 2011r;407:28–33.
Ue T, Yokozaki H, Kagai K, Higashikawa K, Yasui W, Sugiyama M,
et al. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. J Oral Pathol Med. 1998;27:197–201.
Sano T, Hikino T, Xue Q, Saito T, Kashiwabara K, Oyama T, et al. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma. Pathol Int. 2000;50:709–716.
Kudo Y, Takata T, Ogawa I, Sato S, Nikai H. Expression of p53 and p21CIP1/ WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Rep. 1999y;6:539–545.
Mohamed KM, Le A, Duong H, Wu Y, Zhang Q, Messadi DV. Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma. Exp Mol Pathol. 2004;76:143–152.
Choontharu MM, Binda A, Bhat S, Sharma SM. Role of tumor markers in oral squamous cell carcinoma: review of literature and future consideration. SRM J Res Dent Sci. 2012t;3:251–256.
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982v;31:11–24.
Crowe DL, Milo GE, Shuler CF. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res. 1999;78:1256–1263.
Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncology reports. 2007;18:639–644.
Godfroid E, Geuskens M, Dupressoir T, Parent I, Szpirer C. Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells. J Cell Sci. 1991 Jul;99:595–607.
Hembrough TA, Vasudevan J, Allietta MM, Glass WF 2nd, Gonias SL. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci. 1995;108:1071–1082.
Sundstrom B, Stigbrand T. A two-site enzyme-linked immunosorbent assay for cytokeratin 8. Int J Cancer. 1990;46:604–607.
Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004;203:661–671.
Karlsson C, Karlsson MG, Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides. J Histochem Cytochem. 2011;59:1113–1121.
Sternberger LA, Hardy PH Jr, Cuculis JJ, Meyer HG. The unlabeled antibody method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem. 1970;18:315–333.
Lechner MG, Lade S, Liebertz DJ, Prince HM, Brody GS, Webster HR. Breast implant-associated ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer. 2011;117:1478–1489.
Hermann RM, Fuzesi L, Pradier O, Christiansen H, Schmidberger H. Presence of human papillomavirus-18 and Epstein-Barr virus in a squamous cell carcinoma of the tongue in a 20-year-old patient. Case report and review of the current literature. Cancer Radiother. 2004g;8:262–265.
Higa M, Kinjo T, Kamiyama K, Chinen K, Iwamasa T, Arasaki A, et al. Epstein–Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan—Simultaneously infected with human papillomavirus (HPV). Oral Oncol. 2003;39:405–414.
Erdem NF, Carlson ER, Gerard DA. Characterization of gene expression profiles of 3 different human oral squamous cell carcinoma cell lines with different invasion and metastatic capacities. J Oral Maxillofac Surg. 2008;66:918–927.
Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA. Vascular endothelial growth factor-C and C–C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res. 2009;69:349–357.
Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg. 2003;129:760–770.
Warshamana-Greene GS, Litz J, Buchdunger E, Garc-a-Echeverr-a C, Hofmann F, Krystal GW. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer, cell lines to the effects of chemotherapy. Clin Cancer Res J. 2005;11:1563–1571.
Adamsen BL, Kravik L, de Angelis PM. Cellular response to chemoradiotherapy, radiotherapy and chemotherapy in two colorectal cancer cell lines. Radiat Res. 2009;171:562–571.
Nobusawa A, Sano T, Negishi A, Yokoo S, Oyama T. Immunohistochemical staining patterns of cytokeratins 13, 14, and 17 in oral epithelial dysplasia including orthokeratotic dysplasia. Pathol Int. 2014n;64:20–27.
Escobar-Hoyos LF, Yang J, Zhu J, Cavallo JA, Zhai H, Burke S, et al. Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker. Mod Pathol. 2014;27:621–630.
Kitamura R, Toyoshima T, Tanaka H, Kawano S, Kiyosue T, Matsubara R, et al. Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2012;138:1299–1310.
Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW, Ries J. Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2008;134:515–521.
Carrilho C, Alberto M, Buane L, David L. Keratins 8, 10, 13, and 17 are useful markers in the diagnosis of human cervix carcinomas. Hum Pathol. 2004;35:546–551.
Martens J, Baars J, Smedts F, Holterheus M, Kok MJ, Vooijs P, et al. Can keratin 8 and 17 immunohistochemistry be of diagnostic value in cervical cytology? A feasibility study. Cancer. 1999r;87:87–92.
Brotherick I, Robson CN, Browell DA, Shenfine J, White MD, Cunliffe WJ, et al. Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression. Cytometry. 1998;32:301–308.
- Abstract Viewed: 187 times
- PDF Downloaded: 95 times